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Abstract
Genetic studies show that TGFβ signaling is essential for vascular development, although the mechanism through which this pathway operates
is incompletely understood. Here we demonstrate that the TGFβ auxiliary coreceptor endoglin (eng, CD105) is expressed in a subset of neural
crest stem cells (NCSCs) in vivo and is required for their myogenic differentiation. Overexpression of endoglin in the neural crest caused
pericardial hemorrhaging, correlating with altered vascular smooth muscle cell investment in the walls of major vessels and upregulation of
smooth muscle α-actin protein levels. Clonogenic differentiation assay of NCSCs derived from neural tube explants demonstrated that only NCSC
expressing high levels of endoglin (NCSCCD105+) had myogenic differentiation potential. Furthermore, myogenic potential was deficient in
NCSCs obtained from endoglin null embryos. Expression of endoglin in NCSCs declined with age, coinciding with a reduction in both smooth
muscle differentiation potential and TGFβ1 responsiveness. These findings demonstrate a cell autonomous role for endoglin in smooth muscle cell
specification contributing to vascular integrity.
© 2007 Elsevier Inc. All rights reserved.Keywords: Endoglin; Neural crest; Transforming growth factor beta; Myogenesis; CardiovascularIntroduction
Endoglin is an auxiliary receptor that interacts with the
TGFβ signaling receptors (Barbara et al., 1999; Cheifetz et al.,
1992). Endoglin null embryos die by E11.5 due to defects inAbbreviations: BMP, bone morphogenetic protein; eng, endoglin gene;
SMC, smooth muscle cell; Eng, endoglin protein; (α-SMA), smooth muscle
alpha actin; HHT, hereditary hemorrhagic telangiectasia; p75, low affinity nerve
growth factor receptor; Po, myelin P0 protein; GFAP, glial fibrillary acidic
protein; NCSC, neural crest stem cell; TGFβ1, transforming growth factor β1;
ALK, activin receptor-like kinase; TβRII, transforming growth factor beta type
2 receptor; RT-PCR, reverse transcriptase polymerase chain reaction; TUNEL,
terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling
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doi:10.1016/j.ydbio.2007.06.009vessel formation (Arthur et al., 2000; Bourdeau et al., 1999; Li
et al., 1999) characterized by a failure of vascular smooth
muscle cell (SMC) recruitment and loss of expression of the
SMC differentiation marker smooth muscle alpha actin (α-
SMA) (Li et al., 1999), whereas endothelial cells appear normal.
Endoglin is expressed in stem cell populations including
hematopoietic, mesenchymal, and neural stem cells (Chen et
al., 2002; Vogel et al., 2003; Zvaifler et al., 2000). Furthermore,
endoglin is upregulated in SMCs in response to vascular injury
(Ma et al., 2000) and in human atherosclerotic vascular SMCs
(Conley et al., 2000). Mutations in both endoglin and the type I
TGFβ receptor ALK1 cause hereditary hemorrhagic telangiec-
tasia (HHT) types 1 and 2 respectively, disorders characterized
by vessel fragility and arteriovenous malformation (McAllister
et al., 1994; Pece et al., 1997) suggesting that these proteins play
a critical role in vascular homeostasis.
TGFβ ligands and receptors play important roles in the
specification and development of neural crest-derived cell types
(Choudhary et al., 2006; Kaartinen et al., 2004; Shah et al.,
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cell population derived from the neural tube and contributes to
multiple vital developmental processes. Within the neural crest,
a population of cells expressing low affinity nerve growth factor
receptor (p75) and lacking expression of myelin P0 protein
(p75+P0
−) are referred to as neural crest stem cells (NCSCs).
NCSCs differentiate into a variety cell types including neurons,
glia, melanocytes, SMCs and head cartilage and bone
(Anderson, 1997; Bronner-Fraser, 1995). A number of growth
factors instruct differentiation of NCSCs from explants of
embryonic neural tube, sciatic nerve, or intestine. These factors
include BMP2 and BMP4, which instruct neurogenic differ-
entiation (Shah et al., 1996), the soluble Notch ligand, Delta-Fc
(Morrison et al., 2000) and neuregulin (Shah et al., 1994),
which instruct gliogenic differentiation, and TGFβ1, which
instructs SMC differentiation (Chen et al., 2006; Shah and
Anderson, 1997).
Previously, we reported that NCSCs become progressively
more gliogenic and less neurogenic with age (Kubu et al.,
2002). This transition reflects a decrease in sensitivity to BMP2
and an increase in sensitivity to Delta-Fc. These changes
involve altered expression of the BMP type I receptor ALK3
and Notch1 (Kubu et al., 2002; White et al., 2001).
Interestingly, NCSCs retain SMC differentiation potential in
the presence of both BMP and Delta-Fc, demonstrating that the
altered balance between gliogenic and neurogenic fates does not
affect SMC differentiation potential. While the age-related loss
of neurogenic potential is characterized, the effects of age on
SMC myogenic potential of NCSCs remain unknown.
Based on the report of SMC defects in endoglin null embryos
combined with the previous observation of upregulation of
endoglin expression in diseased vascular SMCs and in response
to injury, we investigated the hypothesis that endoglin plays a
cell autonomous role in vascular SMC development and
maintenance of vascular integrity.Materials and methods
Endoglin knockout and transgenic mouse studies
Endoglin null C57Bl6 mice were kindly provided by Dr. D. Marchuk
(Arthur et al., 2000). Transgenic mouse embryos used in this study were
maintained on an FVB background. Mice were maintained according to the NIH
standards established in the Guidelines for the Care and Use of Experimental
Animals. Protocols and procedures were approved by the Institutional Animal
Care and Use Committee at the Maine Medical Center Research Institute. Full
length human endoglin cDNA was blunt end ligated into the CAGCAT vector
(Yamauchi et al., 1999). Microinjection into fertilized FVB oocytes and other
surgical procedures were performed as described (Hofmann et al., 1988). The
genotypes of all offspring were analyzed by PCR as well as by chloramphenicol
acetyl transferase (CAT) enzyme-linked immunosorbent assay, which was used
to normalize the transgene locus CAT activity levels prior to establishment of
mouse lines.
The Wnt1cre driver mouse was used to achieve conditional expression of
endoglin in neural crest stem cells (Jiang et al., 2000). Mating of Wnt1cre with
TgEngloxP generated Wnt1cre;TgEngloxP embryos that were genotyped using
PCR primers as previously described (Chytil et al., 2002). Briefly, yolk sac
genomic DNAwas amplified for 35 cycles (94 °C for 1 min, 60 °C for 1.5 min,
72 °C for 2 min) in a thermal cycler. The primers were GCTGGTTAGCACCG-
CAGGTGTAGAG and CGCCATCTTCCAGCAGGCGCACC in the cre codingregion and CAGAGTGTCCCCATCCGT and TGGGTATGGGTACTGTGTA-
GAAGT in the endoglin coding region.
Conditional inactivation of Smad4 with simultaneous activation of human
endoglin was achieved by breeding Wnt1cre;TgEngloxP on to the Smad4
heterozygous background (Wnt1cre;TgEngloxP;Sm4n/+), and subsequently
intercrossing this strain with the Smad4 conditional strain (SM4c/c) (Chu et
al., 2004). Embryos of two different genotypes resulting from this mating were
analyzed: Wnt1cre;TgEngloxP;Sm4c/+ and Wnt1cre;TgEngloxP;Sm4n/c. The
latter configuration is sensitized to conditional inactivation asWnt1cre-mediated
recombination of only a single allele is required to render the Smad4 locus null.
This strategy was previously used for complete inactivation of the Smad4 locus
in embryonic tissues (Chu et al., 2004).
Histological analysis
X-gal staining was performed according to standard procedures (Hogan
et al., 1994). For hematoxylin and eosin (H&E) staining and immunohisto-
chemistry, embryos were fixed in 4% paraformaldehyde overnight and
subsequently dehydrated through a graded ethanol series and paraffin embedded.
Five micrometer sections were stained with H&E for morphological analysis or
immunohistochemistry was performed using the following antibodies: PECAM
(BD Pharmingen) 1:3000, AP-conjugated α-SMA (Sigma) 1:50, SOX-10 (1:1)
and HNK-1 (1:1) (Anderson and Axel, 1986). PECAM staining was performed
using the TSA Biotin kit (Perkin Elmer) with trypsin antigen retrieval per
manufacturer's instructions. IHC for endoglin was performed using α-human
endoglin (SN6h) 1:500 (Dako). This anti-human endoglin antibody was raised
against human endoglin and was selected for its preferential recognition of
human endoglin. This reagent preferentially detects human endoglin (Rodriguez-
Pena et al., 2002), which was utilized to generate the transgene. Histological
staining forα-SMA, SOX-10 andHNK-1was performed using theAvidin/Biotin
kit (Vector Labs) with citrate buffer antigen retrieval (Dako) following the
manufacturer's instructions. SOX-10 immunofluorescence was conducted using
Alexa-645 labeled anti-mouse antibody (Molecular Probes) at 1:100 dilution for
1 h. Fluorescence was imaged using an Axioskop 2 Plus microscope fitted with
an AxioCam MRm camera (Zeiss). Immunohistochemistry using α-phospho
Smad 1/5/8 (anti-pSmad 1/5/8) and α-phospho Smad 2/3 antibody (anti-pSmad
2/3, Cell Signaling Technology) 1:1000 was performed with citrate retrieval and
the TSA signal amplification system (Perkin Elmer).
Immunoprecipitation and Western blot
Embryos were harvested at E11.5. Whole embryos were dissociated by
passing through a 1 ml syringe into RIPA buffer (50 mM Tris–HCl, pH 7.5,
150 mM NaCl, 300 mM sucrose, 1.0% Triton-X100, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulfate and 10 mM β-glycerol phosphate)
supplemented with a protease inhibitor cocktail (Roche) and processed as
described (Koleva et al., 2006). Bound antibodies were visualized by
chemiluminescence (ECL, Amersham). Anti-human endoglin antibody Clone
35 at 1:2000 (BD Transduction) does not efficiently detect mouse endoglin
(Rodriguez-Pena et al., 2002) and was used to demonstrate cre recombination
and overexpression of the human endoglin transgene in the TgEngloxP
embryos. Endogenous levels of α-SMA and Flk-1 were detected using α-SMA
antibody at 1:1000 (Sigma) and α-Flk-1 antibody at 1:200 (Santa Cruz)
respectively.
Neural crest cell culture
NCSCs were isolated by the method of Stemple (Stemple and Anderson,
1992). In short, neural tubes from E10.5 rat or E9.5 mouse embryos were
isolated between presumptive limb buds and plated on 35 mm fibronectin-
coated dishes. Crest cells were allowed to migrate away from the tube overnight
in a defined medium containing 10% chick embryo extract (CEE). Neural tubes
were then removed using a tungsten needle (Morrison et al., 2000). Explant cells
were trypsinized and plated at clonal density (50 cells per 35 mm dish) in a
growth factor rich medium containing 15% CEE (Morrison et al., 2000) that
enhances autonomic phenotype production (referred to as Morrison medium).
To identify NCSCs, the cells were live labeled with the 192IgG p75 antibody
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myelin protein, P0, was conjugated to phycoerythrin (gift of J. Achelos,
Munich). p75+P0
− cells (migrating NCSCs) were identified and used for analysis.
Once all non-p75+P0
− cells were removed from the dish with a tungsten needle,
the remaining p75+P0
− cells were restained with anti-CD105 antibody
conjugated to PE (anti-CD105-PE, BioCytex) to delineate the NCSCCD105+
and NCSCCD105− stem cells. NCSCCD105+ and NCSCCD105− cell designations
were based on strong or undetectable anti-CD105-PE antibody immunor-
eactivity, respectively, as determined by immunofluorescence microscopy.
In polymerase chain reaction (PCR) experiments, trypsinized crest explants
were plated at 500 cells per dish and labeled with the p75 and P0 antibodies.
E14 sciatic nerve-derived NCSCs were isolated and cultured according to
the method of Morrison (Morrison et al., 1999). Sciatic nerves isolated from E14
embryos, P1 rat pups, and adult (greater than 6 weeks) rats were enzymatically
dissociated and labeled with the p75 antibody conjugated to fluorescein and the
P0 monoclonal antibody conjugated to phycoerythrin. Cells were sorted using a
FACSVantage flow cytometer. The p75+P0
− fraction (NCSCs) was plated at
clonal density for clonogenic assays in Morrison medium, or at higher density
for reverse transcriptase (RT)-PCR studies after staining for CD105-PE to
identify NCSCCD105+ and NCSCCD105− subpopulations.
Clonogenic assays
Clonogenic assays were performed according to the original method of
Stemple (Stemple and Anderson, 1992). Briefly, NCSCs were plated at clonal
density and cultured for up to 14 days in Morrison medium. The resulting clones
were fixed in acid ethanol and stained with antibodies against peripherin
(Chemicon AB1530, Temecula, CA) to detect neurons (N), α-SMA (Sigma A-
2547, St. Louis, MO) to detect myofibroblasts (M) and anti-glial fibrillary acidic
protein (GFAP) antibody (Chemicon AB 5040) to detect Schwann cells (S).
Clones were scored based on the appearance of just one phenotypic
representative (Stemple and Anderson, 1992). The number and percentage of
clones containing neurons only (N), glial cells only (G), myofibroblasts only
(M) and combinations of (N+G), (N+M), (N+G+M) and (G+M) were scored
at day 14 unless stated otherwise. Also scored was the production of each
representative phenotype in each clone to complement our clonal population
assay.
Retroviral mediated gene transfer and reconstitution studies
Overexpression of the genes of interest in NCSCs was achieved by
retroviral-mediated gene transfer as described (Verdi and Anderson, 1994).
Endoglin was cloned into the pWzl retrovirus (Pear et al., 1993), as previously
described (Conley et al., 2004). Virus was produced using the EcoPac-293
packaging cell line (ClonTech). On the day before transfection, the EcoPac-293
cells were split and plated at 2×106 cells per 60 mm dish in DMEM plus 10%
fetal bovine serum. Effectine (Promega) mediated transfection was used to
introduce constructs harboring the genes of interest into the packaging cell line.
Virus was collected for the next 72 h, at which time the virus-containing medium
was divided in half and concentrated according to the method of Cepko (Cepko
et al., 1998). The resulting viral pellet was resuspended in Morrison medium
minus CEE. The concentrated viral stock was added to the NCSC cultures in the
presence of 4 μg/ml polybrene. Two 2-hour rounds of infection were conducted.
Thereafter, the cells were washed, split to clonal density, Morrison medium was
applied and clonogenic differentiation assays were conducted. Infection
efficiencies as measured by GFP or RFP expression ranged from a low of 3%
to a high of over 12%.
RT-PCR
Total RNAwas isolated using the RNA micro-isolation kit (Stratagene). The
RNAwas treated with DNAse to remove potential genomic contamination and
reprecipitated. The resulting RNAwas oligo-dT primed and reverse transcribed
using superscript II as previously described (Verdi and Anderson, 1994). PCR
was performed in the linear range of amplification for each primer set, as
empirically determined using total RNA from 50 and 500 cell equivalents.
Primers were chosen to have an annealing temperature of approximately 55 °Cwith a 50–60% GC content. The primers were chosen to span an intron/exon
border to avoid amplification of any residual genomic DNA.
Results
Endoglin is expressed in the neural crest, in areas along the
A/P axis that give rise to vascular smooth muscle cells
Endoglin targeted (eng−/−) embryos die by E11.5 due to
defects in angiogenesis and cardiac morphogenesis resulting in
septation defects suggesting a loss of endocardial to mesench-
ymal transitions and a possible absence of vascular SMCs (Li et
al., 1999). This interpretation was suggested by a loss of α-
SMA staining in eng−/− embryos, however α-SMA is first
detected in wild type embryos at E11.5 and therefore it is
unclear whether loss of endoglin results in a delay or loss of
SMC specification and/or differentiation. Since many of the
SMCs that invest the large vessels and form the cardiac
cushions are derived from the neural crest (Jiang et al., 2000),
we sought to characterize a role for endoglin in the neural crest
by determining whether endoglin is expressed in neural crest
cells in vivo. Using the heterozygous eng mouse with the β-
galactosidase cDNA expressed from the eng locus (Arthur et
al., 2000), we observed endoglin-expressing cells surrounding
the neural tube, a location typical for neural crest cells (Fig. 1A).
To determine if these endoglin-expressing cells were neural
crest cells, we performed immunohistochemistry for two neural
crest markers, HNK-1 (Minarcik and Golden, 2003) and SOX-
10 (Young et al., 2004), on β-galactosidase-stained sections
through the neural tube at E9.5 (Figs. 1B, D). Endoglin in E9.5
eng+/− embryos was co-expressed with both HNK-1 and SOX-
10 in some but not all such cells, indicating that endoglin is
expressed in a subset of neural crest cells. To confirm these
results, we isolated NCSCs (Morrison et al., 1999) and
demonstrated by RT-PCR analysis that isolated NCSCs
expressed endoglin, as well as the TGFβ type I receptors
ALK1 and ALK5 (Fig. 1E). Because NCSCs display a graded
loss in developmental potential along the rostrocaudal axis
(Lwigale et al., 2004), we examined endoglin expression along
the rostrocaudal axis. We found that endoglin expression
correlated with areas of the neural crest that give rise to vascular
SMCs; β-galactosidase-stained sections representing an ante-
rior to posterior series through the cardiac crest suggested that
neural crest cells in this region expressed endoglin. However,
endoglin was not expressed in more posterior regions of the
neural crest that do not give rise to smooth muscle, but was
restricted to the vasculature derived from the mesoderm in this
area (Figs. 1F–J). Taken together, these results demonstrate that
endoglin is spatially expressed in the neural crest, in regions that
give rise to vascular SMCs.
Vascular defects are associated with endoglin overexpression
in the neural crest
To determine if eng−/− embryos exhibit defective SMC
specification or differentiation, we performed converse in vivo
gain of function analysis to determine if increased endoglin
Fig. 1. Endoglin is expressed in the neural crest in vivo. (A) Section of embryo in which LacZ is inserted into the endoglin locus is stained for β-galactosidase activity.
Cells expressing β-galactosidase under control of the endogenous endoglin promoter and indicating endoglin gene transcriptional activity around the neural tube. (B)
β-galactosidase staining of eng+/− embryos in combination with HNK-1 immunostaining. Arrow indicates an example of a cell expressing β-galactosidase (blue)
under the control of the endoglin promoter and HNK-1 immunostaining (red). (C, D) β-Galactosidase staining of eng+/− embryo section (C) in combination with SOX-
10 immunofluorescence (D). Arrows indicate examples of cells expressing both β-galactosidase (green cells, C) and which exhibit immunofluorescent staining for
SOX-10 (red cells, D). (E) RT-PCR analysis of NCSC isolated from E10.5 rat neural tube for the TGFβ receptors ALK1, ALK5 and endoglin, as well as the low-
affinity nerve growth factor, p75. β-Actin serves as a control. (F–J) Schematic of an eng+/− E9.5 embryo (F) and corresponding sections stained for β-galactosidase
(G–J) demonstrating endoglin expression in the neural crest along the anterior–posterior axis. Note that endoglin expression is restricted to the vasculature in more
posterior regions of the neural crest.
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SMCs derived from the neural crest. For these studies, we
generated a cre-inducible transgenic mouse line conditionally
expressing endoglin (TgEngloxP) (Fig. 2A). TgEngloxP mice
were bred to Wnt1cre mice to induce expression of the
TgEngloxP transgene in cells of the neural crest (Jiang et al.,
2002). In vivo cre recombination and subsequent expression of
the eng transgene were confirmed by immunoprecipitation and
immunoblotting for endoglin protein from whole Wnt1cre;
TgEngloxP embryos (Fig. 2B). Immunohistochemistry for trans-
genic endoglin expression in the Wnt1cre;TgEngloxP embryos,
conducted using an anti-endoglin antibody that preferentially
recognizes human endoglin (Rodriguez-Pena et al., 2002),
confirmed that endoglin was upregulated in neural crest-derived
tissues relative to wild type (Figs. 2C, D). Wnt1cre;TgEngloxPembryos consistently displayed dilated cranial vessels and
bleeding in the thoracic cavity (Figs. 2E, G). Lethality was
observed in the majority of Wnt1cre;TgEngloxP embryos by
E18.5.
Histological analysis of serial transverse sections through the
outflow tract and major vessels revealed hemorrhaging into the
pericardial cavity (Figs. 2F, H). While no gross malformations
were observed in the heart that resulted in hemorrhaging, the
overall morphology of the Wnt1cre;TgEngloxP heart exhibited
thinning of the atrial walls (Fig. 2H versus F). TUNEL staining
did not indicate increased cell death in the Wnt1cre;TgEngloxP
compared to wild type mice (data not shown). Additionally,
phospho-histone H3 staining did not reveal differences in
proliferation in the heart and surrounding vasculature (data not
shown). These data suggested that vascular leakage in the
Fig. 2. Overexpression of endoglin in the neural crest in vivo resulted in vascular hemorrhage. (A) Schematic of transgenic strategy and resulting construct upon
Wnt1cre-mediated recombination. (B) Immunoprecipitation of human endoglin followed by immunoblot analysis of E11.5 wild type andWnt1cre;TgEngloxP embryos.
(C, D) α-Human endoglin antibody immunohistochemistry was conducted using the human endoglin-specific SN6h anti-endoglin antibody (Bodey et al., 1998;
Rodriguez-Pena et al., 2002) on sections from E12.5 wild type and Wnt1cre;TgEngloxP transgenic embryos. Arrows indicate that increased endoglin expression was
restricted to neural crest-derived structures. Neural crest-derived structures are: OT=outflow tract; DRG=dorsal root ganglia; DA=ductus arteriosus. (E, G) E12.5
wild type and Wnt1cre;TgEngloxP transgenic whole embryos. Arrows indicate areas of hemorrhaging in the cranial vasculature and heart in Wnt1cre;TgEngloxP
embryos. (F, H) H&E staining of transverse heart sections from E12.5 wild type (F) and Wnt1cre;TgEngloxP (H) embryos. Asterisks indicate areas of hemorrhaging in
the pericardial cavity; arrows indicate areas of atrial wall thinning.
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structural integrity, potentially involving neural crest-derived
SMCs.
Endoglin overexpression does not effect the migration of
NCSCs
Previous work implicates endoglin in the regulation of cell
migration (Conley et al., 2004; Guerrero-Esteo et al., 1999), and
therefore we determined if the vascular defects were due to
inhibition of migration of neural crest-derived SMC precursorsto major vessels and the outflow tract of the developing heart.
TgEngloxP mice were bred with R26R mice bearing a cre-
inducible LacZ reporter (TgEngloxP;R26R) (Jiang et al., 2000;
Soriano, 1999). These mice were subsequently bred to the
Wnt1cre driver, to label endoglin-overexpressing neural crest
cells and their derivatives. Analysis of transverse sections
through the heart region of E12.5 embryos revealed little effect
of endoglin overexpression on the number of neural crest cells in
this region using this technique (Figs. 3A–E), indicating that a
defect in cell migration was not likely the cause of this
phenotype.
Fig. 3. Vascular hemorrhaging in vivo is correlated with an increase in disorganized vascular SMCs. (A) β-Galactosidase staining of a transverse section through the
anterior region of the heart of an E12.5 Wnt1cre;R26R embryo reveals the structures arising from NCSCs, including the major vessels (black box) and outflow tract
(red box). (B, C) Higher magnification of Wnt1cre;R26R and Wnt1cre;TgEngloxP;R26R highlights major vessels and (D, E) cardiac outflow tract. (F, G) α-SMA
immunohistochemical analysis of major vessels of E12.5Wnt1cre;TgEndloxP embryos compared to wild type. The higher magnification view shows the layer of SMCs
was thicker and less compact in Wnt1cre;TgEndloxP vessels and the individual SMCs demonstrated a rounded morphology (note areas delimited by red bars within
black box). (H, I) Immunohistochemical staining for PECAM in sections adjacent to (F, G).
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SMC development
The loss of blood vessel integrity in Wnt1cre;TgEngloxP
embryos could be due to a disturbance in development of the
vascular SMC layer. Indeed, examination of the major vessels
surrounding the hearts of E12.5 Wnt1cre;TgEngloxP;R26R
embryos using the SMC marker α-SMA and the endothelial
specific marker PECAM revealed disorganization of SMCs
(Figs. 3F, G) with normal endothelial morphology (Figs.
3H, I). Furthermore, the SMC layer in the vessel was broader
and less compact in the Wnt1cre;TgEngloxP embryos compared
to wild type (insets, Figs. 3F, G). The SMCs had a rounded
morphology, which is indicative of defects in cell spreadingand adhesion (Foo et al., 2006). These data suggest that the
embryonic defects result from aberrant SMC differentiation and
organization. However, while the number of neural crest cells
was similar between the wild type and Wnt1cre;TgEngloxP
embryos (Figs. 3B–E), these data suggested that there was
enhancement of smooth muscle cell differentiation in Wnt1cre;
TgEngloxP embryos.
The effects of endoglin overexpression on neural crest-derived
SMCs are potentially Smad-independent
Neural crest smooth muscle specification is thought to be
regulated by TGFβ- and Smad-dependent signaling (Chen and
Lechleider, 2004). Because endoglin acts as an auxiliary cell-
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(Barbara et al., 1999), we wanted to ascertain whether the
cardiovascular defects in Wnt1cre;TgEngloxP embryos could be
directly due to hyperactivation of TGFβ or BMP signaling.
Therefore, we looked to see if endoglin was effecting Smad
activation. The degree of activation of BMP and TGFβ
signaling in neural crest-derived structures was assayed by
immunohistochemical staining for phosphorylated forms of the
Smad transcription factors, which are the most thoroughly
characterized effectors of TGFβ signaling. Immunohistochem-
istry using an antibody that recognizes the phosphorylated
receptor-restricted Smads, pSmad 1/5/8, which mediate BMP
signaling (Figs. 4A, B) or pSmad 2/3, which mediate TGFβ
signaling (Figs. 4C, D), revealed no differences in Smad
phosphorylation in neural crest-derived structures between
Wnt1cre;TgEngloxP and wild type embryos. Importantly, there
was no alteration in Smad phosphorylation in the aberrant
SMCs in the Wnt1cre;TgEngloxP embryos. Thus, overexpres-Fig. 4. Overexpression of endoglin in vivo results in aberrant neural crest-derived SMC
Smad 2/3 antibody immunohistochemistry in E12.5Wnt1cre;TgEngloxP (B, D) compa
1/5/8-expressing cells in the wall of the vessel (red boxes in panels A and B) and no ec
as revealed by (E–H) H&E analysis of sections through the heart region of E11 embry
allele on the heterozygous null background (Wnt1cre;Sm4c/n) alone or (H) in comp
simultaneously inactivated in neural crest cells (Wnt1cre;Sm4c/n;TgEngloxP). Aste
arteriosus (PTA) in panel H which is absent in panels E–G. (I) Immunoblot analys
Wnt1cre;TgEngloxP embryos compared to wild type. (J) Endoglin immunopreci
recombination in wild type versus SM22αcre;TgEngloxP transgenic embryos. (K) Imm
compared to wild type embryos.sion of endoglin in NCSCs does not lead to increased levels of
phosphorylated Smads characteristic of amplified pathway
activation.
To verify that the effect of endoglin overexpression in the
neural crest is independent of hyperactivation of the
canonical TGFβ and BMP signaling pathways, we generated
compound mutant mice in which endoglin was overexpressed
and Smad4 was simultaneously inactivated in neural crest
cells (Wnt1cre;Sm4c/n;TgEngloxP) (Chu et al., 2004). Smad4
is required for the canonical signaling responses to the
TGFβ-, activin- and BMP-related ligands (Shi and Massague,
2003) and represents a tractable target for conditional
inactivation of Smad-dependent TGFβ receptor signaling. If
endoglin overexpression hyperactivated canonical TGFβ
signaling, we predicted that inactivation of Smad4 should
ameliorate the cardiovascular defects seen when endoglin is
overexpressed in NCSCs. However, if endoglin were operat-
ing in a distinct pathway, inactivation of Smad4 would eithers independently of Smads. (A, B) α-Phospho Smad 1/5/8 and (C, D) α-phospho
red to wild type (A, C) embryos. Note that there is a similar percentage of pSmad
topic expression of pSmad 2/3 in the neural crest-derived vessels (arrows, C, D),
os which are either (E) wild type, (F) Wnt1cre;TgEngloxP, (G) Smad4 conditional
ound mutant mouse embryos in which endoglin is overexpressed and Smad4 is
risks indicate hemorrhaging (F). Arrow indicates region of persistent truncus
is of total α-SMA (vascular smooth muscle) and Flk-1 (endothelium) in E11.5
pitation followed by immunoblot analysis of endoglin expression upon cre
unoblot analysis of total α-SMA in E11.5 SM22αcre;TgEngloxP whole embryos
527M.L. Mancini et al. / Developmental Biology 308 (2007) 520–533have no effect on or could exacerbate the Wnt1cre;TgEngloxP
phenotype. Indeed, we found exacerbation of the Wnt1cre;
TgEngloxP phenotype upon simultaneous inactivation of
Smad4. Wnt1cre;Sm4c/n;TgEngloxP embryos demonstrated
characteristic defects in the outflow tract, persistent truncus
arteriosus, in which there was a loss of septation of the aorta
and pulmonary trunk which form the outflow tract (Fig. 4H).
This defect was not observed in wild type (Fig. 4E) or
Wnt1cre;Sm4c/n embryos (Fig. 4G). Consistent with the data
shown in Fig. 2F, hemorrhaging was observed in the
Wnt1cre;TgEngloxP sections (Fig. 4F). As shown in Figs.
4E–H, hearts of compound Wnt1cre;Sm4c/n;TgEngloxP
embryos displayed a malformation more severe than in
Wnt1cre;TgEngloxP embryos. Collectively, these results strongly
suggest that endoglin is operating in a pathway or pathways
separate from or overlapping with canonical TGFβ receptor
signaling.
Endoglin expression affects SMC specification
To further understand the role of endoglin in SMC
differentiation from neural crest, we performed whole
embryo immunoprecipitation of α-SMA at E11.5 followed
by immunoblot analysis. Immunoblotting demonstrated that
total protein levels of α-SMA were consistently higher in the
Wnt1cre;TgEngloxP embryos compared to the wild type
control embryos (Fig. 4I). Consistent with immunohistochem-
ical data, no differences were observed in total protein levels of
the endothelial cell marker Flk-1 (Fig. 4I). This result
contrasted with use of the SM22αcre driver to activate the
expression of the TgEngloxP transgene in specified SMC,
where total protein levels of α-SMA were similar in
SM22αcre;TgEngloxP embryos compared to wild type (Fig.
4K). We confirmed that in vivo cre recombination and
subsequent expression of the endoglin transgene also occurred
using the SM22αcre driver (Fig. 4J). Because SM22α
expression occurs in committed SMC (Solway et al., 1995),
whereas Wnt1cre activates endoglin expression in a progenitor
population (Choudhary et al., 2006), these data provide
confirmation that neural crest-expressed endoglin affected
SMC specification.
Endoglin is required for SMC differentiation potential of
NCSCs
To further understand the functional role of endoglin in SMC
differentiation from neural crest stem cells, we performed
clonogenic differentiation assays (Stemple and Anderson,
1992). The SMC differentiation potential of p75+P0
− NCSCs
isolated from explants of rat E10.5 neural tubes was evaluated
by two parameters: (i) the generation of SMC-only containing
clones (M-only), defined by expression of α-SMA, and (ii) the
production of clones containing SMCs (i.e. M-Containing) as
well as glia or neuronal cells (N-Containing), or both as defined
by expression of the markers GFAP and peripherin, respec-
tively. Isolated NCSCs could be divided into two populations
based on endoglin expression determined by the presence orabsence of CD105 staining (data not shown), hereafter referred
to as NCSCCD105+ and NCSCCD105−, which was consistent with
our expression data in embryos showing that only a subpopula-
tion of migrating neural crest cells express endoglin (Fig. 1).
The NCSCCD105− population of cells constituted approximately
25% of the total P75+P0
− NCSCs isolated. We therefore explored
the possibility that differences in SMC differentiation potential
existed between NCSCCD105+ and NCSCCD105−. Lack of
endoglin expression in the NCSCCD105− population correlated
with impaired SMC differentiation potential as demonstrated by
a decrease in the generation of M-Containing clones (Fig. 5A),
which are defined as clones containing at least one SMC actin-
positive cell (Kubu et al., 2002; Shah and Anderson, 1997).
NCSCCD105− and NCSCCD105+ were equally capable of pro-
ducing clones containing neuronal cells, indicating that this was
not due to an overall decrease in differentiation capacity. SMC
differentiation potential of NCSCCD105+ was enhanced by
treatment with 5 pM TGFβ1. However, NCSCCD105− failed to
show enhanced M-Containing clone production in response to
TGFβ1 (Fig. 5A), even when the concentration of TGFβ1 was
increased by one order of magnitude (data not shown).
Reconstitution of endoglin expression restores SMC
differentiation potential in NCSCCD105−
The observation that NCSCCD105− were impaired in their
capacity for SMC differentiation established a correlation
between the levels of endoglin expression and SMC differentia-
tion potential. Interestingly, reconstitution of endoglin expres-
sion in NCSCCD105− by retroviral transduction restored SMC
differentiation potential, compared to either control-transduced
or uninfected NCSCCD105− (Fig. 5B). In addition to demon-
strating a causal relationship between endoglin expression and
SMC differentiation potential, this experiment indicated that
NCSCCD105+ population contained the necessary signaling
components for SMC differentiation.
Endoglin null NCSCs exhibit loss of SMC potential
We next sought to determine whether endoglin was required
for the myogenic differentiation potential of NCSCs. To address
this question, NCSCs were isolated from E9.5 eng−/−, eng+/−,
and wild type (eng+/+) neural tube explants. Clonogenic
differentiation assays demonstrated that eng−/− NCSCs were
deficient in their SMC differentiation potential as compared to
eng+/+ and eng+/− clones (Fig. 5C). Clonogenic differentiation
assays for SMC potential of eng−/− NCSCs in response to
TGFβ1 also demonstrated minimal SMC progeny (Fig. 5D).
These results provide strong support for the hypothesis that
endoglin is required for SMC differentiation from NCSCs.
NCSCs undergo age-related loss of SMC differentiation
potential and endoglin expression
As previously described, the neurogenic potential of NCSCs
decreases as gliogenic potential increases during develop-
ment (Kubu et al., 2002; White et al., 2001). Therefore, we
Fig. 5. Endoglin is required for myogenic differentiation of NCSCs. (A) Clonogenic differentiation assays from E10.5 rat neural tube explants can be divided into two
populations based on endoglin expression. Presented are the percentages of clones scored that were neural-containing (N-Containing) or smooth muscle-containing
(M-Containing), which were defined as clones containing one or more cells of that type, as determined by marker analysis. NCSCCD105+ relative to NCSCCD105−
exhibit a higher myogenic differentiation potential. Myogenic differentiation in NCSCCD105− can not be restored to that of NCSCCD105+ by treatment with TGFβ1.
Presented are the means±standard deviation of three independent experiments. (B) Reconstitution of endoglin expression in NCSCCD105− via retroviral transduction.
Presented are the means±standard deviation of four experiments originating from distinct cell isolations, identifications and retroviral transduction. (C) Clonogenic
differentiation assay of NCSCs isolated from E9.5 wild type eng+/+, heterozygous eng+/−, and eng null eng−/− embryos. (D) Clonogenic differentiation assay of
NCSCs isolated from E9.5 eng+/+ and eng−/− embryos treated with TGFβ1. Values presented are the means±standard deviation of three separate experiments.
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affected during development and in the adult. Comparison of
the myogenic potential of NCSCs derived from E10.5 neural
tube explants and E12.5 and adult (N6 weeks) sciatic nerve
explants showed that in adult NCSCs, there was a significant
(pb .025) decline in the ability to form M-Containing clones
into adulthood compared with those isolated at E10.5. This
result suggested that myogenic potential decreased with age
(Fig. 6A). To assess the sensitivity of NCSCs to TGFβ1 as a
function of age, we examined the ability of TGFβ1 to instruct
SMC differentiation over a developmental time course (Figs.
6B, C). Interestingly, the frequency of NCSCs generating M-
only clones steadily declined with age, even in the presence of
increasing doses of TGFβ1 (Fig. 6B). The concentration that
produced a half-maximal response [EC50] increased from 500
pM at E10.5 to 650 pM at E14, and to 1600 pM in NCSCs in the
adult (Fig. 6B). Whereas TGFβ1 enhanced the overallproduction of α-SMA-positive clones, the myogenic activity
of TGFβ1 significantly decreased with age; overall, 88±6% of
E10.5 NCSCs were competent to respond to TGFβ1 and
produce myogenic clones, compared to 48±12% of adult cells
(Fig. 6C).
Studies addressing NCSC maturation demonstrated quanti-
tative changes in the expression of genes in the pathways
involved in instructive signaling events (Kubu et al., 2002;
White et al., 2001). The loss of neurogenic potential is
associated with a loss of the expression of the BMP type I
receptor ALK3, and enhanced gliogenic differentiation is
correlated with an increase in Notch expression (Kubu et al.,
2002; Morrison et al., 1999; White et al., 2001). Therefore, we
asked whether there is a similar age-related decline in TGFβ
signaling components and subsequent SMC differentiation
potential of NCSCs. Interestingly, the age-related loss of SMC
differentiation potential in NCSCs did not correlate with
Fig. 6. Myogenic differentiation potential of NCSCs decrease with age with a concomitant decrease in endoglin expression and responsiveness to TGFβ1. (A)
Clonogenic differentiation assays conducted using P75+P0
−NCSC isolated from E10.5 neural tube and E14 and adult sciatic nerve. Production of muscle-only (M-only)
and M-Containing clones is compared. Presented are the means±standard deviation of three experiments. (B, C) NCSCs isolated from E10.5, E14 and adult animals
are evaluated for the production of clones containing (B) only myogenic progeny (M-only) or (C) containing at least one differentiated myogenic cell (M-Containing)
in response to TGFβ1. Presented are the means±standard deviation of three experiments representing a minimum of 200 clones scored. (D) RT-PCR of NCSCs
isolated at different time points for the TGFβ type I receptors ALK1 and ALK5, and the low affinity nerve growth factor receptor (p75). Levels of β-actin serve as a
control. (E) NCSCs were identified from E10 neural tube explants 12 h after isolation and culturing in Morrison media. Non-NCSCs were removed from the dish and
the remaining cells stained for Endoglin expression. A similar strategy was used on FACS isolated P75+P0
− NCSC from the sciatic nerve of E14 and adult rats.
Presented are the means±SD of two experiments originating from distinct isolations.
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ALK1 or ALK5 which remained unchanged (Fig. 6D). In
contrast, endoglin mRNA expression in NCSCs decreased withage (Fig. 6D) and was accompanied by corresponding changes
in endoglin protein expression. Approximately 75–85% of
NCSCs that were isolated from E10.5 neural tube expressed
530 M.L. Mancini et al. / Developmental Biology 308 (2007) 520–533endoglin compared with 10–20% from the adult sciatic nerve
(Fig. 6E). As scored by the number of clones present at the end
of the experiment (day 3), this number never dropped below
95% and there was no significant difference between any of the
conditions. Thus, clone survival was not a significant
contributor to these results.
Taken together, these findings demonstrate that endoglin
expression decreases with age in NCSCs, which correlates with
a decrease in responsiveness to TGFβ1 and SMC differentiation
potential.
Discussion
Appropriate specification of stem cell fates is essential for
normal vertebrate development. NCSCs give rise to a variety of
cell types, including neurons, glia and the SMCs of the major
vessels and outflow tract of the heart (Fig. 7). NCSCs undergo
age-related changes in their ability to respond to instructive
signals (Kubu et al., 2002). For example, a decline in neuronal
versus glial differentiation of NCSCs with age is well
established. Neurogenic specification is instructed by BMP2
and BMP4, and age-related decreases in neurogenic differentia-
tion potential can be attributed to decreases in the levels of the
BMP type I receptor, ALK3. TGFβ1 was identified as an
instructive myogenic signal for NCSCs (Chen and Lechleider,
2004; Gadson et al., 1997); however, the mechanisms
governing NCSC differentiation potential remain poorly under-
stood. Clonogenic assay of neural crest stem cells demonstrated
a requirement for endoglin in SMC differentiation from NCSCs
because SMC differentiation was blocked in the absence of
endoglin, even in the presence of TGFβ1. We note that subtle
differences in cell proliferation between populations would not
contribute to the observed changes in clone composition
because situations in which there was either 1 neuron and
1000 glia or 500 neurons and 5000 glia were still recorded as a
neuron-containing or glia-containing clone. Similarly, signifi-
cant differences in cell survival in the clonogenic assay could beFig. 7. Endoglin is required for the myogenic differentiation potential of neural cr
undergo age-related loss of endoglin expression. Loss of endoglin expression is accom
TGFβ, resulting in impaired myogenic potential, whereas other cell fates are not affexcluded because of the absence of α-SMA-positive and
annexin V-positive cells. Additionally, we also used Hoechst
staining to look for nuclear fragmentation of α-SMA-positive
cells and this result was also negative (data not shown).
Furthermore, we showed that similar to neurogenic differ-
entiation potential of NCSCs, SMC differentiation potential
decreased with age. However, the loss of potential correlated
with a loss of endoglin expression, not with loss of the TGFβ
type I receptors ALK1 or ALK5. These data agree with recent
findings that human mesenchymal stem cells expressing
endoglin demonstrated the capacity for SMC differentiation
potential (Roura et al., 2006), suggesting that endoglin may
have a general role in SMC differentiation of stem cell
populations.
Endoglin has been extensively studied in endothelial cells;
however, an important role in SMC differentiation is suggested
by the phenotype of the null mouse (Arthur et al., 2000;
Bourdeau et al., 1999; Li et al., 1999). Eng−/− embryos die by
E11.5 due to defects in angiogenesis characterized by failure of
SMC differentiation and investment accompanied by normal
endothelial development (Arthur et al., 2000; Bourdeau et al.,
1999; Li et al., 1999). From analysis of the endoglin loss of
function phenotype, it is unclear whether endoglin plays an
essential cell autonomous role in SMC, or if impaired SMC
development is secondary to a lack of endoglin expression in
the endothelium. For the first time, data presented in this study
demonstrate an intrinsic, cell autonomous role for endoglin in
SMC precursors.
Overexpression of endoglin in neural crest cells resulted in
pronounced hemorrhaging in cranial vessels and the pericar-
dial cavity. Hemorrhaging and aberrant SMCs in the wall of
the vessels did not appear to be associated with cell death or
proliferation as measured by TUNEL and phospho-histone H3
staining, respectively. Hemorrhaging into the pericardial sac
could have resulted from defects in the junction between the
smooth muscle and the myocardium, arising from perturba-
tion of the secondary heart field with altered patterning of theest stem cells. The schematic summarizes the findings suggesting that NCSCs
panied by a decrease in their responsiveness to the myogenic instructive ligand
ected.
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demonstrated that migration of endoglin overexpressing
NCSCs to vessel walls is comparable with wild type, arguing
against a migration defect as the origin of the vascular
phenotype. Furthermore, skewing of NCSC fates secondary to
endoglin overexpression is unlikely because we show that
NCSCCD105+ and NCSCCD105− were both capable of producing
neuronal and glial cells. This finding was corroborated in vivo
because endoglin specifically affected neural crest-derived
SMC; whereas other neural crest derivatives including cranio-
facial structures, branchial arches and dorsal root ganglion (data
not shown) were grossly normal.
Importantly, hemorrhaging was not observed in the trunk
vessels, where the contribution of NCSCs to SMC is absent.
Hemorrhaging was ostensibly due to decreased vascular
integrity secondary to disorganization of SMCs in the walls of
major vessels, an area populated by Wnt1-expressing cells. In
addition, SMC disorganization was accompanied by an
apparent increase in the number of SMCs. Upregulation of α-
SMA expression in endoglin-expressing NCSCs is consistent
with data suggesting enhanced SMC differentiation. We cannot
exclude the possibility of an increase in total α-SMA protein
expression in the same number of SMC. However, over-
expression of endoglin using the SM22αcre driver had no effect
on total protein levels of α-SMA. This observation suggests that
the effect of endoglin expression on SMC differentiation is
specific to stem cell populations and does not impact committed
progenitors.
An explanation for the disorganization and rounded
morphology of SMCs secondary to endoglin overexpression
is alteration in the cell adhesive properties. Previously, we
demonstrated: (i) a role for endoglin in regulating cell
adhesion through interactions with the focal adhesion protein,
zyxin, and (ii) subsequent modulation of the levels of p130Cas
and Crk in sites of focal adhesion (Conley et al., 2004). Like
endoglin, Ephrin B2 is highly expressed in vascular
endothelial cells with lower levels of expression seen in
vascular SMCs. Conditional inactivation of Ephrin B2 in
SMCs results in impaired mural cell attachment surrounding
the vessels due to an apparent lack of focal adhesions and
altered Crk-p130Cas signaling (Foo et al., 2006). More
recently, mice in which Notch signaling was specifically
inactivated in derivatives of the neural crest exhibited aortic
arch patterning defects, pulmonary artery stenosis and
ventricular septal defects (High et al., 2007). Immunohisto-
chemical examination of mutant arteries revealed disruption of
the smooth muscle architecture that is similar to that seen in
Fig. 3. Similarly, overexpression of endoglin may modulate
interactions with proteins such as zyxin and zyxin-related
protein-1 (Conley et al., 2004; Sanz-Rodriguez et al., 2004),
thus modifying adhesive properties of SMCs. Therefore, we
propose that the observed cardiovascular phenotype of the
Wnt1cre;TgEngloxP might be due to a combination of
enhanced SMC differentiation potential accompanied by
defects in cellular adhesion. These results are consistent with
a cell autonomous role for endoglin in the maintenance of
vascular integrity through SMC differentiation and adhesion.Although TGFβ1 is implicated in SMC differentiation in
vitro (Chen and Lechleider, 2004; Shah and Anderson, 1997),
recent studies in vivo suggest that TGFβ1 signaling in neural
crest does not specify SMCs. Surprisingly, conditional
inactivation of ALK5 and TβRII in the neural crest results in
normal SMC differentiation (Choudhary et al., 2006; Wang et
al., 2006). Thus in vivo, it appears that factors other than
TGFβ1 specify SMC from neural crest. Interestingly, Wnt1cre
conditional inactivation of the putative BMP receptor ALK2
results in impaired SMC differentiation (Kaartinen et al., 2004).
We showed by anti-phospho Smad 2/3 and anti-phospho Smad
1/5/8 antibody immunostaining that endoglin overexpression
had no apparent effect on canonical TGFβ or BMP receptor
signaling. Furthermore, a compound mutant in which the
Smad4 transcription factor is inactivated simultaneously with
endoglin overexpression suggests that there is no epistatic
relationship between these two genes, indicating that they
operate in distinct pathways. In this regard, our data suggesting
the lack of involvement of canonical signaling are consistent
with recent studies indicating that α-SMA expression in
response to TGFβ involves Smad-independent signaling
(Chen et al., 2006). These results support our hypothesis that
endoglin plays a Smad-independent role in SMC differentiation
from NCSCs in vivo.
Involvement of endoglin in non-canonical signaling was
previously suggested based on the phenotypic comparison
between the eng−/− and TAK1−/− mouse strains (Jadrich et al.,
2006). TAK1 is a non-canonical Smad-independent effector of
TGFβ signaling. Similar to the eng−/− mouse, SMC develop-
ment was impaired with normal endothelial cell development
(Jadrich et al., 2006), thereby raising the possibility that TAK1
may act downstream of endoglin.
Accumulating evidence suggests that the precursors of HHT
lesions may occur early in human development (Mei-Zahav et
al., 2006; Morgan et al., 2002). Our data suggest that vascular
smooth muscle precursor cells that are deficient in endoglin may
contribute to the formation of lesions that can appear later in
life. By elucidating the molecular mechanisms through which
endoglin functions, we will better understand the process of
SMC differentiation and homeostasis. These findings may
provide further insight into the vascular disorder HHT, which is
caused by haploinsufficiency of endoglin with resulting
vascular fragility. Moreover, we propose that these insights
may be applicable to other stem cell populations with SMC
differentiation potential such as mesenchymal stem cells, which
also express endoglin (Vogel et al., 2003; Zvaifler et al., 2000)
and are involved in vasculogenesis (Gojo et al., 2003).
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